NASDAQ:LHCG - LHC Group Stock Price, Price Target & More

$74.31 +0.91 (+1.24 %)

(As of 04/20/2018 06:24 AM ET)

Previous Close$73.40

Today's Range$72.67 - $74.32

52-Week Range$51.61 - $76.14

Volume224,300 shs

Average Volume295,744 shs

Market Capitalization$1.34 billion

P/E Ratio30.97

Dividend YieldN/A

Beta0.7

About LHC Group (NASDAQ:LHCG)

LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services. The Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. The Community-Based Services segment offers a range of services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand services to patients in their home or in a medical facility. The Facility-Based Services segment serves patients suffering from respiratory failure, neuromuscular disorders, cardiac disorders, non-healing wounds, renal disorders, cancer, head and neck injuries, and mental disorders, as well as treats patients diagnosed with musculoskeletal impairments. The company also operates institutional pharmacy, a family health center, a rural health clinic, and a retail pharmacy, as well as offers physical therapy services. As of December 31, 2017, it operated 318 home health services locations, 91 hospice locations, 12 community-based service locations, and 11 long-term acute care hospitals with 15 locations. LHC Group, Inc. was founded in 1994 and is based in Lafayette, Louisiana.

Receive LHCG News and Ratings via Email

Sign-up to receive the latest news and ratings for LHCG and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Home health care services

Sub-IndustryHealth Care Services

SectorMedical

SymbolNASDAQ:LHCG

CUSIP50187A10

Webwww.lhcgroup.com

Phone337-233-1307

Debt

Debt-to-Equity Ratio0.28%

Current Ratio1.97%

Quick Ratio1.97%

Price-To-Earnings

Trailing P/E Ratio30.97

Forward P/E Ratio21.23

P/E Growth1.18

Sales & Book Value

Annual Sales$1.07 billion

Price / Sales1.27

Cash Flow$3.2464 per share

Price / Cash22.89

Book Value$28.54 per share

Price / Book2.60

Profitability

EPS (Most Recent Fiscal Year)$2.42

Net Income$50.11 million

Net Margins4.67%

Return on Equity9.18%

Return on Assets5.94%

Miscellaneous

Employees14,554

Outstanding Shares18,280,000

How to Become a New Pot Stock Millionaire

LHC Group (NASDAQ:LHCG) Frequently Asked Questions

What is LHC Group's stock symbol?

LHC Group trades on the NASDAQ under the ticker symbol "LHCG."

How were LHC Group's earnings last quarter?

LHC Group, Inc. (NASDAQ:LHCG) released its quarterly earnings results on Wednesday, February, 28th. The health services provider reported $0.62 earnings per share (EPS) for the quarter, hitting the Thomson Reuters' consensus estimate of $0.62. The health services provider earned $292.40 million during the quarter, compared to analysts' expectations of $280.82 million. LHC Group had a return on equity of 9.18% and a net margin of 4.67%. The company's revenue for the quarter was up 24.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.58 earnings per share. View LHC Group's Earnings History.

When is LHC Group's next earnings date?

LHC Group is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for LHC Group.

What guidance has LHC Group issued on next quarter's earnings?

LHC Group issued an update on its FY18 earnings guidance on Monday, April, 2nd. The company provided earnings per share (EPS) guidance of $3.45-3.55 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.09.

What price target have analysts set for LHCG?

10 Wall Street analysts have issued 1 year price objectives for LHC Group's stock. Their forecasts range from $71.00 to $85.00. On average, they anticipate LHC Group's share price to reach $77.5556 in the next year. View Analyst Ratings for LHC Group.

Who are some of LHC Group's key competitors?

Some companies that are related to LHC Group include Ironwood Pharmaceuticals (IRWD), Evotec A.G. (EVTCY), Teladoc (TDOC), Abcam (ABC), CRISPR Therapeutics (CRSP), Acadia Pharmaceuticals (ACAD), Intrexon (XON), Select Medical (SEM), Puma Biotechnology (PBYI), Tenet Healthcare (THC), Akorn (AKRX), USANA Health Sciences (USNA), National Vision (EYE), Supernus Pharmaceuticals (SUPN), Global Blood Therapeutics (GBT), Horizon Pharma (HZNP), Merit Medical Systems (MMSI) and The Medicines (MDCO).

Who are LHC Group's key executives?

LHC Group's management team includes the folowing people:

Mr. Keith G. Myers, Co-Founder, Chairman & CEO (Age 59)
Mr. Donald D. Stelly, Pres & COO (Age 49)
Mr. Joshua L. Proffitt, Exec. VP of Corp. Devel., CFO & Treasurer (Age 40)
Mr. John L. Indest, Consultant & Director (Age 66)
Mr. John M. Thompson Jr., Sr. VP & Chief Information Officer

Has LHC Group been receiving favorable news coverage?

News articles about LHCG stock have trended somewhat positive recently, according to Accern. The research group identifies positive and negative media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. LHC Group earned a media sentiment score of 0.09 on Accern's scale. They also gave press coverage about the health services provider an impact score of 47.00 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

How do I buy shares of LHC Group?

Shares of LHCG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is LHC Group's stock price today?

One share of LHCG stock can currently be purchased for approximately $74.31.

How big of a company is LHC Group?

LHC Group has a market capitalization of $1.34 billion and generates $1.07 billion in revenue each year. The health services provider earns $50.11 million in net income (profit) each year or $2.42 on an earnings per share basis. LHC Group employs 14,554 workers across the globe.

How can I contact LHC Group?

LHC Group's mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The health services provider can be reached via phone at 337-233-1307 or via email at [email protected]

MarketBeat Community Rating for LHC Group (LHCG)

Community Ranking:		2.3 out of 5 ( )
Outperform Votes:		207 (Vote Outperform)
Underperform Votes:		237 (Vote Underperform)
Total Votes:		444

MarketBeat's community ratings are surveys of what our community members think about LHC Group and other stocks. Vote "Outperform" if you believe LHCG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LHCG will underperform the S&P 500 over the long term. You may vote once every thirty days.

LHC Group (NASDAQ:LHCG) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

10 Wall Street analysts have issued ratings and price targets for LHC Group in the last 12 months. Their average twelve-month price target is $77.5556, suggesting that the stock has a possible upside of 4.37%. The high price target for LHCG is $85.00 and the low price target for LHCG is $71.00. There are currently 1 hold rating and 9 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.90	2.90	2.90	2.89
Ratings Breakdown:	0 Sell Rating(s) 1 Hold Rating(s) 9 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 9 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 9 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 8 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$77.5556	$77.4444	$76.8889	$66.5556
Price Target Upside:	4.37% upside	26.81% upside	20.33% upside	2.16% upside

LHC Group (NASDAQ:LHCG) Consensus Price Target History

Price Target History for LHC Group (NASDAQ:LHCG)

LHC Group (NASDAQ:LHCG) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/4/2018	Craig Hallum	Boost Price Target	Buy	$70.00 -> $80.00	High
4/4/2018	Jefferies Group	Reiterated Rating	Buy -> Buy	$84.00	High
3/2/2018	Stephens	Set Price Target	Buy	$74.00	Low
12/7/2017	Oppenheimer	Reiterated Rating	Buy	$85.00	Low
11/28/2017	Robert W. Baird	Set Price Target	Hold	$71.00	Low
11/21/2017	William Blair	Reiterated Rating	Outperform		N/A
11/7/2017	Royal Bank of Canada	Boost Price Target	Outperform -> Outperform	$70.00 -> $81.00	N/A
11/3/2017	SunTrust Banks	Reiterated Rating	Buy	$75.00	N/A
8/21/2017	Bank of America	Initiated Coverage	Buy -> Buy	$76.00	Low
6/8/2017	Benchmark	Boost Price Target	Buy -> Buy	$63.00 -> $72.00	Medium

(Data available from 4/20/2016 forward)

LHC Group (NASDAQ:LHCG) Earnings History and Estimates Chart

Earnings by Quarter for LHC Group (NASDAQ:LHCG)

LHC Group (NASDAQ:LHCG) Earnings Estimates

2018 EPS Consensus Estimate: $3.43
2019 EPS Consensus Estimate: $4.01

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	4	$0.53	$0.61	$0.58
Q2 2018	4	$0.77	$0.90	$0.84
Q3 2018	4	$0.91	$0.97	$0.94
Q4 2018	4	$0.98	$1.17	$1.07
Q1 2019	3	$0.81	$0.89	$0.85
Q2 2019	3	$0.93	$1.03	$0.99
Q3 2019	3	$1.00	$1.07	$1.03
Q4 2019	3	$1.08	$1.21	$1.13

LHC Group (NASDAQ LHCG) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/1/2018		$0.62					N/A
2/28/2018	Q4 2017	$0.62	$0.62	$280.82 million	$292.40 million	View	Listen
11/6/2017	Q3 2017	$0.60	$0.64	$265.35 million	$272.90 million	View	N/A
8/2/2017	Q2 2017	$0.54	$0.6290	$254.10 million	$260.20 million	View	Listen
5/3/2017	Q1 2017	$0.44	$0.48	$241.64 million	$246.62 million	View	N/A
3/8/2017	Q4 2016	$0.57	$0.58	$233.82 million	$235.44 million	View	Listen
11/2/2016	Q316	$0.50	$0.54	$224.60 million	$230.00 million	View	N/A
8/3/2016	Q2	$0.52	$0.52	$221.09 million	$226.00 million	View	N/A
5/4/2016	Q116	$0.37	$0.44	$214.41 million	$222.60 million	View	Listen
3/2/2016	Q415	$0.46	$0.53	$213.35 million	$219.00 million	View	N/A
11/4/2015	Q315	$0.43	$0.50	$199.40 million	$204.10 million	View	Listen
8/5/2015	Q215	$0.41	$0.51	$193.75 million	$200.20 million	View	Listen
5/6/2015	Q115	$0.35	$0.39	$188.90 million	$193.10 million	View	N/A
2/25/2015	Q414	$0.33	$0.45	$190.25 million	$193.40 million	View	Listen
11/5/2014	Q314	$0.34	$0.36	$185.00 million	$187.70 million	View	N/A
8/6/2014	Q214	$0.32	$0.35	$179.90 million	$188.90 million	View	Listen
5/7/2014	Q114	$0.27	$0.24	$166.15 million	$163.70 million	View	Listen
3/5/2014	Q413	$0.32	$0.29	$168.74 million	$165.30 million	View	Listen
11/6/2013	Q313	$0.31	$0.31	$167.61 million	$164.70 million	View	N/A
8/7/2013	Q2 2013	$0.28	$0.34	$166.50 million	$166.30 million	View	N/A
5/8/2013	Q1 2013	$0.33	$0.37	$164.68 million	$162.00 million	View	N/A
3/6/2013	Q4 2012	$0.37	$0.43	$160.93 million	$161.80 million	View	N/A
11/7/2012	Q312	$0.37	$0.36	$159.89 million	$158.90 million	View	N/A
8/6/2012		$0.39	$0.35			View	N/A
5/2/2012		$0.36	$0.44			View	N/A
2/29/2012		$0.35	$0.39			View	N/A
11/2/2011		$0.56	($2.08)			View	N/A
8/3/2011		$0.50	$0.56			View	N/A
5/5/2011		$0.36	$0.42			View	N/A
3/2/2011		$0.66	$0.63			View	N/A
11/1/2010	Q3 2010	$0.69	$0.73			View	N/A
8/4/2010	Q2 2010	$0.70	$0.68			View	N/A
4/28/2010	Q1 2010	$0.65	$0.64			View	N/A
3/3/2010	Q4 2009	$0.51	$0.70			View	N/A
10/28/2009	Q3 2009	$0.52	$0.54			View	N/A
8/4/2009	Q2 2009	$0.53	$0.57			View	N/A
5/6/2009	Q1 2009	$0.48	$0.62			View	N/A
3/10/2009	Q4 2008	$0.46	$0.60			View	N/A
10/29/2008	Q3 2008	$0.36	$0.45			View	N/A
7/30/2008	Q2 2008	$0.31	$0.35			View	N/A
4/30/2008	Q1 2008	$0.28	$0.31			View	N/A
2/27/2008	Q4 2007	$0.38	$0.39			View	N/A

(Earnings results data provided by Zacks Investment Research)

LHC Group (NASDAQ:LHCG) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

LHC Group (NASDAQ LHCG) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 14.80%
Institutional Ownership Percentage: 89.91%

Insider Trading History for LHC Group (NASDAQ:LHCG)

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

LHC Group (NASDAQ LHCG) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/13/2018	Donald Dwayne Stelly	COO	Sell	14,216	$64.00	$909,824.00
9/8/2017	Donald Dwayne Stelly	COO	Sell	2,650	$65.34	$173,151.00	109,235
6/16/2017	Coliseum Capital Management, L	Director	Sell	14,450	$65.69	$949,220.50
6/9/2017	Coliseum Capital Management, L	Director	Sell	10,215	$65.14	$665,405.10
6/8/2017	Donald Dwayne Stelly	COO	Sell	3,181	$64.97	$206,669.57	114,235
6/7/2017	Coliseum Capital Management, L	Director	Sell	162,524	$62.80	$10,206,507.20
6/6/2017	Coliseum Capital Management, L	Director	Sell	25,000	$63.23	$1,580,750.00
6/5/2017	Coliseum Capital Management, L	Director	Sell	77,524	$61.73	$4,785,556.52
6/2/2017	Coliseum Capital Management, L	Director	Sell	145,850	$61.05	$8,904,142.50
5/30/2017	Coliseum Capital Management, L	Director	Sell	107,463	$60.63	$6,515,481.69
5/19/2017	Coliseum Capital Management, L	Director	Sell	8,632	$60.25	$520,078.00
5/11/2017	Coliseum Capital Management, L	Director	Sell	128,000	$60.99	$7,806,720.00
3/17/2017	Coliseum Capital Management, L	Director	Sell	51,900	$50.26	$2,608,494.00
3/15/2017	Joshua L Proffitt	Insider	Sell	6,984	$51.54	$359,955.36	71,589
3/13/2017	Donald Dwayne Stelly	COO	Sell	13,154	$51.81	$681,508.74	128,089
12/16/2016	Keith G Myers	CEO	Sell	31,139	$43.91	$1,367,313.49	144,615
12/13/2016	Keith G Myers	CEO	Sell	33,261	$43.58	$1,449,514.38	144,615
12/12/2016	Coliseum Capital Management, L	Director	Sell	50,100	$43.41	$2,174,841.00
12/1/2016	Coliseum Capital Management, L	Director	Sell	26,000	$42.70	$1,110,200.00
11/29/2016	Coliseum Capital Management, L	Director	Sell	18,228	$43.29	$789,090.12
11/29/2016	Keith G Myers	CEO	Sell	15,652	$43.64	$683,053.28	144,615
11/23/2016	Keith G Myers	CEO	Sell	44,897	$43.54	$1,954,815.38	144,615
11/22/2016	Keith G Myers	CEO	Sell	7,214	$43.53	$314,025.42	144,615
11/21/2016	Keith G Myers	CEO	Sell	18,423	$43.54	$802,137.42	144,615
11/18/2016	Keith G Myers	CEO	Sell	2,203	$43.53	$95,896.59	144,615
11/17/2016	Coliseum Capital Management, L	Director	Sell	45,776	$43.19	$1,977,065.44
11/16/2016	Keith G Myers	CEO	Sell	37,848	$43.69	$1,653,579.12	144,615
11/7/2016	Donald Dwayne Stelly	COO	Sell	2,651	$41.54	$110,122.54	119,216
11/7/2016	Joshua L Proffitt	Insider	Sell	2,098	$41.80	$87,696.40	64,717
8/22/2016	Kenneth E Thorpe	Director	Sell	1,450	$36.88	$53,476.00	17,550
6/10/2016	Joshua L Proffitt	EVP	Sell	5,444	$42.65	$232,186.60	47,817
6/9/2016	Coliseum Capital Management, L	Director	Sell	140,000	$43.64	$6,109,600.00
6/8/2016	Donald Dwayne Stelly	COO	Sell	1,326	$43.55	$57,747.30	124,216
5/27/2016	Keith G Myers	CEO	Sell	49,000	$41.09	$2,013,410.00	170,938
5/25/2016	Keith G Myers	CEO	Sell	126,000	$41.96	$5,286,960.00	300,881
5/24/2016	Keith G Myers	CEO	Sell	75,000	$42.19	$3,164,250.00	300,881
5/23/2016	Keith G Myers	CEO	Sell	21,000	$41.16	$864,360.00	300,881
3/14/2016	Donald Dwayne Stelly	COO	Sell	12,952	$35.51	$459,925.52	96,764
2/3/2016	Keith G Myers	CEO	Sell	55,000	$36.60	$2,013,000.00	282,326
1/5/2016	Keith G Myers	CEO	Sell	55,000	$43.13	$2,372,150.00	282,326
1/4/2016	Keith G Myers	CEO	Sell	24,300	$43.47	$1,056,321.00	282,326
12/11/2015	Coliseum Capital Management, L	Director	Sell	54,000	$45.90	$2,478,600.00
12/2/2015	Coliseum Capital Management, L	Director	Sell	24,549	$46.13	$1,132,445.37
12/2/2015	Keith G Myers	CEO	Sell	55,000	$46.20	$2,541,000.00	282,326
12/1/2015	Coliseum Capital Management, L	Director	Sell	124,905	$46.09	$5,756,871.45
11/30/2015	Coliseum Capital Management, L	Director	Sell	18,580	$47.09	$874,932.20
11/27/2015	Ronald T Nixon	Director	Sell	1,695	$48.06	$81,461.70	35,200
11/18/2015	Donald Dwayne Stelly	COO	Sell	1,353	$45.36	$61,372.08	87,615
11/17/2015	Coliseum Capital Management, L	Director	Sell	56,017	$45.48	$2,547,653.16
11/12/2015	Coliseum Capital Management, L	Director	Sell	78,000	$47.24	$3,684,720.00
11/9/2015	Donald Dwayne Stelly	COO	Sell	4,732	$47.35	$224,060.20	89,615
11/2/2015	Keith G Myers	CEO	Sell	55,000	$45.67	$2,511,850.00	283,391
10/5/2015	Keith G Myers	CEO	Sell	55,000	$43.28	$2,380,400.00	283,391
9/11/2015	Coliseum Capital Management, L	Director	Sell	285,846	$46.67	$13,340,432.82
9/8/2015	Coliseum Capital Management, L	Director	Sell	147,671	$46.96	$6,934,630.16
9/1/2015	Keith G Myers	CEO	Sell	55,000	$43.54	$2,394,700.00	283,391
8/19/2015	Coliseum Capital Management, L	Director	Sell	13,818	$47.68	$658,842.24
8/17/2015	Coliseum Capital Management, L	Director	Sell	77,390	$47.56	$3,680,668.40
7/7/2015	Keith G Myers	CEO	Sell	21,651	$37.47	$811,262.97
7/2/2015	Keith G Myers	CEO	Sell	33,349	$37.31	$1,244,251.19
6/12/2015	Coliseum Capital Management, L	Director	Sell	169,987	$36.51	$6,206,225.37
6/9/2015	Coliseum Capital Management, L	Director	Sell	15,606	$36.36	$567,434.16
6/9/2015	Donald Dwayne Stelly	COO	Sell	1,724	$36.20	$62,408.80
6/5/2015	Coliseum Capital Management, L	Director	Sell	88,494	$36.29	$3,211,447.26
6/4/2015	Ronald T Nixon	Director	Sell	4,000	$36.25	$145,000.00
6/3/2015	Keith G Myers	CEO	Sell	16,800	$36.04	$605,472.00
6/2/2015	Keith G Myers	CEO	Sell	38,200	$36.96	$1,411,872.00
5/6/2015	Keith G Myers	CEO	Sell	17,505	$30.09	$526,725.45
5/5/2015	Keith G Myers	CEO	Sell	37,495	$31.22	$1,170,593.90
3/12/2015	Donald Dwayne Stelly	COO	Sell	11,753	$32.27	$379,269.31
3/12/2015	Joshua L Proffitt	EVP	Sell	3,317	$32.37	$107,371.29
9/8/2014	Donald Dwayne Stelly	COO	Sell	4,732	$24.98	$118,205.36
8/27/2014	Keith G Myers	CEO	Sell	48,018	$25.66	$1,232,141.88
8/22/2014	Keith G Myers	CEO	Sell	24,234	$25.24	$611,666.16
8/21/2014	John L Indest	Director	Sell	4,200	$25.22	$105,924.00
8/21/2014	Keith G Myers	CEO	Sell	44,631	$25.23	$1,126,040.13
8/20/2014	Coliseum Capital Management, L	Director	Sell	62,000	$25.32	$1,569,840.00
8/20/2014	Keith G Myers	CEO	Sell	77,351	$25.33	$1,959,300.83
8/18/2014	Coliseum Capital Management, L	Director	Sell	158,011	$25.60	$4,045,081.60
8/18/2014	Donald Dwayne Stelly	COO	Sell	1,725	$25.62	$44,194.50
8/18/2014	Joshua L Proffitt	EVP	Sell	1,294	$25.58	$33,100.52
5/13/2014	Donald Dwayne Stelly	COO	Sell	10,472	$21.08	$220,749.76	97,775
5/12/2014	Joshua Proffitt	EVP	Sell	1,908	$21.13	$40,316.04	27,715
3/14/2014	Ted Hoyt	Director	Sell	5,000	$21.85	$109,250.00	34,550
3/10/2014	Ted Hoyt	Director	Sell	5,000	$22.35	$111,750.00	34,550
9/10/2013	Donald Dwayne Stelly	COO	Sell	1,354	$23.05	$31,209.70
8/13/2013	Donald Dwayne Stelly	COO	Sell	1,723	$26.08	$44,935.84	62,885
8/12/2013	Ted Hoyt	Director	Sell	1,000	$26.36	$26,360.00	36,950
6/13/2013	Keith G Myers	CEO	Sell	9,662	$22.91	$221,356.42
6/12/2013	Keith G Myers	CEO	Sell	61,500	$22.44	$1,380,060.00
6/11/2013	Coliseum Capital Management, L	Director	Buy	14,000	$22.20	$310,800.00
6/7/2013	Keith G Myers	CEO	Sell	11,547	$22.08	$254,957.76
6/4/2013	Keith G Myers	CEO	Sell	33,000	$22.45	$740,850.00
5/30/2013	Keith G Myers	CEO	Sell	32,738	$22.51	$736,932.38
5/24/2013	Keith G Myers	CEO	Sell	26,553	$22.54	$598,504.62
5/13/2013	John L Indest	Director	Sell	5,900	$22.76	$134,284.00
3/15/2013	Coliseum Capital Management, L	Director	Buy	27,201	$21.18	$576,117.18
3/12/2013	Coliseum Capital Management, L	Director	Buy	128,400	$19.89	$2,553,876.00
12/14/2012	Coliseum Capital Management, L	Director	Buy	44,100	$20.49	$903,609.00
12/4/2012	Donald Dwayne Stelly	COO	Sell	4,117	$19.52	$80,363.84
11/29/2012	Coliseum Capital Management, L	Director	Buy	101,200	$18.75	$1,897,500.00
9/5/2012	Coliseum Capital Management, L	Major Shareholder	Buy	34,947	$17.45	$609,825.15
8/8/2012	Coliseum Capital Management, L	Major Shareholder	Buy	84,546	$16.54	$1,398,390.84

(Data available from 1/1/2013 forward)

LHC Group (NASDAQ LHCG) News Headlines

Source:

Date	Headline
	LHC Group Announces First Quarter 2018 Earnings Release and Conference Call Dates finance.yahoo.com - April 19 at 5:17 PM
	SunTrust Banks Comments on LHC Group, Inc.'s Q2 2018 Earnings (LHCG) www.americanbankingnews.com - April 19 at 6:26 AM
	$294.55 Million in Sales Expected for LHC Group, Inc. (LHCG) This Quarter www.americanbankingnews.com - April 19 at 3:06 AM
	BidaskClub Downgrades LHC Group (LHCG) to Buy www.americanbankingnews.com - April 18 at 5:48 PM
	$0.60 Earnings Per Share Expected for LHC Group, Inc. (LHCG) This Quarter www.americanbankingnews.com - April 17 at 1:17 PM
	LHC Group (LHCG) Cut to "Hold" at BidaskClub www.americanbankingnews.com - April 16 at 9:16 AM
	Signature Healthcare prepping to expand this line of business in 2019 finance.yahoo.com - April 12 at 9:18 AM
	LHC Group, Inc. (LHCG) Given Consensus Rating of "Buy" by Analysts www.americanbankingnews.com - April 11 at 5:43 PM
	Active-Investors: Free Post Earnings Research Report: LHC Group's Quarterly Revenue Surged 24.2%; Adjusted EPS Gained 7% www.finanznachrichten.de - April 10 at 8:58 AM
	Free Post Earnings Research Report: LHC Group’s Quarterly Revenue Surged 24.2%; Adjusted EPS Gained 7% finance.yahoo.com - April 10 at 8:58 AM
	LHC Group (LHCG) Upgraded to Buy at BidaskClub www.americanbankingnews.com - April 10 at 8:27 AM
	LHC Group (LHCG) Downgraded by Zacks Investment Research to "Hold" www.americanbankingnews.com - April 7 at 11:01 PM
	Can The Uptrend Continue for LHC Group (LHCG)? finance.yahoo.com - April 6 at 5:19 PM
	Analysts Offer Predictions for LHC Group, Inc.'s Q1 2018 Earnings (LHCG) www.americanbankingnews.com - April 6 at 6:23 AM
	Almost Family, LHC Group execs on what's next after merger www.bizjournals.com - April 5 at 10:44 AM
	Zacks.com highlights: LHC Group, Steel Dynamics, Zebra Technologies, Landstar System, and Science Applications International finance.yahoo.com - April 5 at 10:44 AM
	LHC Group, Inc. Forecasted to Post FY2019 Earnings of $4.20 Per Share (LHCG) www.americanbankingnews.com - April 5 at 9:22 AM
	Oppenheimer Comments on LHC Group, Inc.'s FY2018 Earnings (LHCG) www.americanbankingnews.com - April 5 at 8:52 AM
	William Blair Brokers Raise Earnings Estimates for LHC Group, Inc. (LHCG) www.americanbankingnews.com - April 5 at 7:58 AM
	5 Solid Earnings Growth Stocks for Stupendous Returns finance.yahoo.com - April 4 at 3:53 PM
	Jefferies Group Begins Coverage on LHC Group (LHCG) www.americanbankingnews.com - April 4 at 12:55 PM
	LHC Group (LHCG) Upgraded to "Hold" by BidaskClub www.americanbankingnews.com - April 4 at 12:53 PM
	LHC Group (LHCG) Earns "Buy" Rating from Craig Hallum www.americanbankingnews.com - April 4 at 11:54 AM
	Q2 2018 EPS Estimates for LHC Group, Inc. Boosted by William Blair (LHCG) www.americanbankingnews.com - April 4 at 6:26 AM
	Q2 2018 Earnings Estimate for LHC Group, Inc. (LHCG) Issued By Oppenheimer www.americanbankingnews.com - April 4 at 6:26 AM
	LHC Group up 7% on new Medicare policy expanding coverage for non-skilled home health services seekingalpha.com - April 3 at 5:11 PM
	LHC Group Announces Successful Completion and Effectiveness of Merger with Almost Family finance.yahoo.com - April 2 at 9:08 AM
	LHC Group (LHCG) Releases FY18 Earnings Guidance www.americanbankingnews.com - April 2 at 8:50 AM
	Zacks: Analysts Anticipate LHC Group, Inc. (LHCG) Will Announce Quarterly Sales of $294.74 Million www.americanbankingnews.com - April 2 at 3:04 AM
	LHC Group (LHCG) Price Target Raised to $83.00 www.americanbankingnews.com - April 1 at 4:48 PM
	Royal Bank of Canada Increases LHC Group (LHCG) Price Target to $81.00 www.americanbankingnews.com - April 1 at 4:16 PM
	LHC Group's (LHCG) "Buy" Rating Reaffirmed at Craig Hallum www.americanbankingnews.com - April 1 at 3:42 PM
	LHC Group (LHCG) Stock Rating Upgraded by Zacks Investment Research www.americanbankingnews.com - April 1 at 1:34 PM
	LHC Group (LHCG) Rating Lowered to Hold at Zacks Investment Research www.americanbankingnews.com - March 31 at 4:56 PM
	LHC Group (LHCG) vs. The Competition Financial Survey www.americanbankingnews.com - March 29 at 9:20 PM
	LHC Group and Almost Family Announce Stockholder Approval and Closing of Merger of Equals Transaction finance.yahoo.com - March 29 at 5:09 PM
	LHC Group (LHCG) Upgraded to Hold at Zacks Investment Research www.americanbankingnews.com - March 26 at 12:45 PM
	BidaskClub Upgrades LHC Group (LHCG) to "Sell" www.americanbankingnews.com - March 25 at 9:51 AM
	LHC Group (LHCG) Upgraded to "Sell" by BidaskClub www.americanbankingnews.com - March 24 at 6:14 PM
	LHC Group (LHCG) Rating Increased to Strong-Buy at Zacks Investment Research www.americanbankingnews.com - March 24 at 12:06 PM
	Reviewing LHC Group (LHCG) and Davita (DVA) www.americanbankingnews.com - March 24 at 7:14 AM
	Evercore Set to Join S&P MidCap 400; MGP Ingredients and Tabula Rasa HealthCare to Join S&P SmallCap 600 finance.yahoo.com - March 22 at 8:55 AM
	Comparing LHC Group (LHCG) and Its Rivals www.americanbankingnews.com - March 19 at 3:08 AM
	LHC Group, Inc. (LHCG) Receives Average Recommendation of "Buy" from Analysts www.americanbankingnews.com - March 17 at 5:30 PM
	Understanding LHC Group’s Financial Performance finance.yahoo.com - March 15 at 5:43 PM
	LHC Group, Inc. (LHCG) COO Sells $909,824.00 in Stock www.americanbankingnews.com - March 14 at 7:29 PM
	LHC Group, Inc. (LHCG) Expected to Post Earnings of $0.60 Per Share www.americanbankingnews.com - March 14 at 11:27 AM
	What’s Almost Family’s Business Strategy? finance.yahoo.com - March 14 at 9:12 AM
	Analysts’ Recommendations for Almost Family and Peers in March finance.yahoo.com - March 14 at 9:12 AM
	LHC Group (LHCG) Downgraded to Strong Sell at BidaskClub www.americanbankingnews.com - March 11 at 4:41 PM

LHC Group (NASDAQ:LHCG) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

LHC Group (NASDAQ:LHCG) Income Statement, Balance Sheet and Cash Flow Statement

LHC Group (NASDAQ LHCG) Stock Chart for Friday, April, 20, 2018

Loading chart…

This page was last updated on 4/20/2018 by MarketBeat.com Staff